Clinical trial
Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers
NCT02968498 is registered in ClinicalTrials.gov with Fresenius Kabi as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood Glucose Response After Oral Intake of Lactulose in Healthy Volunteers
- Lead sponsor
- Fresenius Kabi
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- November 30, 2016
- Completion date
- February 28, 2017
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
blood glucose